Skip to main content
Equibles
PACS logo

PACS · PACS Group, Inc. · Metrics

Track PACS — free

Use PACS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PACS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$47.85 -0.91 (-1.87%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$7.72B
Shares
158.34M
Volume · Oct 27 749K Avg daily vol (3M) 803.08K

PACS metrics

83 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$47.85
Market cap
$7.72B

Price action

20 metrics
Price change (1W)
+6.3%
Price change (30D)
+13.2%
Price change (3M)
+3.6%
Price change (6M)
+38.2%
Price change (YTD)
+27.0%
Price change (1Y)
+285.2%
Trailing year
Price change (5Y)
—
52-week high
$48.76
52-week low
$10.58
Change from 52-week high
+0.0%
Change from 52-week low
+360.9%
Annualized volatility
93.3%
Annualized volatility (3M)
35.1%
Beta
0.2
RSI (14D)
67.1
Price vs SMA 50
+11.3%
Price vs SMA 200
+23.2%
Avg volume (3M)
806,444
Relative volume
1.4
Average dollar volume
$35.92M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
158.34M

Valuation

12 metrics
P / E (TTM)
28.5
Trailing earnings · reciprocal yield 3.5%
PEG ratio
0.6
EV / revenue
1.4×
reciprocal yield 72.8%
EV / EBITDA
—
EV / EBIT
18.6×
reciprocal yield 5.4%
P / sales
1.4×
reciprocal yield 73.6%
P / book
6.8
reciprocal yield 14.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
13.2
reciprocal yield 7.6%
Earnings yield
3.6%

Historical valuation

8 metrics
P / E historical average (3Y)
23.2×
reciprocal yield 4.3%
P / E historical average (5Y)
23.2×
reciprocal yield 4.3%
EV / revenue historical average (3Y)
1.0×
reciprocal yield 105.3%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 105.3%
EV / EBIT historical average (3Y)
14.6×
reciprocal yield 6.9%
EV / EBIT historical average (5Y)
14.6×
reciprocal yield 6.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
7.4%
Trailing 12 months
Net margin
4.8%
Gross profit (TTM)
—
Operating profit (TTM)
$410.32M
Net income (TTM)
$269.17M
Trailing 12 months
Diluted EPS (TTM)
$1.71
FCF margin
—
Effective tax rate
29.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.05

Growth

11 metrics
Revenue growth YoY
+9.1%
Year over year
Net income growth YoY
+49.9%
Revenue (TTM)
$5.55B
Trailing 12 months
EPS growth YoY
+51.6%
Shares change YoY
-2.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+29.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
+1.4%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
24.2%
Return on assets
4.8%
Debt / equity
0.2
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
13.9
Net debt / EBITDA
—
Return on invested capital
24.2%
Trailing 12 months
Net cash
−$81.64M
Latest balance sheet
Cash & equivalents
$164.45M
Total assets
$5.66B
Total debt
$246.09M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$573.25M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$74.44M
R&D / revenue
—
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
243
13F filer change QoQ
+24
Institutional ownership
32.4%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
7.1%
Private-fund adviser ownership
6.5%
Active holders' share change QoQ
+5.7%
Holder tenure
6.9
Price vs estimated holder cost
+53.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
5.0%

Short interest

3 metrics
Short interest
2.7%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$58.48M
Insider-sentiment score
52 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 2001184 CUSIP 69380Q107 13F (30d) 40 filings 40 filers Visit website Investor relations